Phase I trial of tivantinib and sorafenib in patients with liver cancer

Trial Profile

Phase I trial of tivantinib and sorafenib in patients with liver cancer

Recruiting
Phase of Trial: Phase I

Latest Information Update: 06 Oct 2009

At a glance

  • Drugs Tivantinib (Primary) ; Sorafenib
  • Indications Liver cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 06 Oct 2009 Status changed from planning to recruiting, according to an ArQule media release.
    • 08 Apr 2009 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top